Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke
Open Access
- 1 July 1998
- journal article
- editorial
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 65 (1) , 1-9
- https://doi.org/10.1136/jnnp.65.1.1
Abstract
No abstract availableKeywords
This publication has 92 references indexed in Scilit:
- Thrombolytic Therapy with Streptokinase in Acute Ischemic StrokeNew England Journal of Medicine, 1996
- Blood—Brain Barrier Permeability and Brain Concentration of Sodium, Potassium, and Chloride during Focal IschemiaJournal of Cerebral Blood Flow & Metabolism, 1994
- Comparison of gene expression of extracellular matrix molecules in brain microvascular endothelial cells and astrocytesBiochemical and Biophysical Research Communications, 1992
- Neurothelin: an inducible cell surface glycoprotein of blood-brain barrier-specific endothelial cells and distinct neurons.The Journal of cell biology, 1990
- Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease.Stroke, 1988
- Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery.Stroke, 1988
- Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.Stroke, 1988
- Ischemic brain edema with and without reperfusion: an experimental study in gerbils.Stroke, 1983
- Temporal profile of neuronal damage in a model of transient forebrain ischemiaAnnals of Neurology, 1982
- Experimental brain infarcts in cats. II. Ischemic brain edema.Stroke, 1980